Emerging viral infections are among the greatest challenges in the public health sector in
the twenty-first century. Among these, most of the viruses jump from other species of animals …

Transchromosomic bovines (Tc-bovines) adaptively produce fully human polyclonal
immunoglobulin (Ig) G antibodies after exposure to immunogenic antigen (s). The National …

Passive antibody immunotherapeutics directed against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are promising countermeasures for protection and treatment of …

Globally, viral illness propagation is the leading cause of morbidity and death, causing
wreaking havoc on socioeconomic development and health care systems. The rise of …

Influenza remains a global health risk and challenge. Currently, neuraminidase (NA)
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …

COVID-19 is a devastating pandemic responsible for the current global health crisis.
Hyperimmune milk, produced after maternal immunisation of bovines, equines, camels …

In December 2019 a novel coronavirus was detected in Wuhan City of Hubei Province-
China. Owing to a high rate of transmission from human to human, the new virus called …

Middle East respiratory syndrome coronavirus (MERS-CoV) induces severe aggravating
respiratory failure in infected patients, frequently resulting in mechanical ventilation. As …

Preclinical development of and research on potential Middle East respiratory syndrome
coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are …

To address the unmet needs for human polyclonal antibodies both as therapeutics and
diagnostic reagents, building upon our previously established transchromosomic (Tc) cattle …